What impact are boosters having on illness and death in Australia? The distinct patterns of vaccination and infection across different states could already be giving a clear clue on booster efficacy.
What do we know about Deltacron? The hybrid variant contains elements of both Delta and Omicron, and has already been identified in multiple countries.
T cells provide long-lasting immunity against COVID: Study According to new Australian research, the T cell response to COVID-19 lasts for at least 15 months.
Complacency concerns as BA.2 spreads: ‘We need to be wary’ COVID-19 infection rates are trending upwards in most Australian states and territories, with winter right around the corner.
How does Omicron compare with Delta? Infectious diseases physician Sanjaya Senanayake details what is known about infectiousness, symptoms, severity and vaccine protection.
Boosters’ Omicron impact outlined in vaccination tool update GPs and patients can now generate personalised information on the risks and benefits associated with choosing whether or not to receive a booster shot.
RACGP urges action on NT COVID-19 spread Hospitalisations are rising in the territory, with doctors concerned about complacency and the knock-on effects for primary care.
Do current COVID-19 vaccines and treatments neutralise Omicron? New research has looked into a number of medications currently approved for use in Australia, as well as the role of a booster shot against the highly-infectious variant.
Online tool aims to guide COVID patients on when to seek medical help Healthdirect’s COVID-19 Symptom Checker is available now and has the potential to ease the burden on general practice and hospitals.
What does the Omicron sub variant mean for Australia’s pandemic response? Detected in at least 40 countries, including Australia, BA.2 is described as being ‘stealthier’ than the original version of Omicron.